A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study
Clinical trial NCT01711814 · COMPLETED
Trial details
- NCT number
- NCT01711814
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-26
- Primary completion
- 2016-03-25
- Enrollment
- 611
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.